Brasilia zeroes tariffs on six strategic imports and multiplies a medical device quota, using a Mercosur supply mechanism to cool input costs while the world’s tariff walls rise International Trade Desk, Peacock Tariff Consulting | July 21, 2026 BRASILIA, July 21, 2026: Brazil has moved in the opposite direction of much of the trading world…
Tariff advisory for Boston biotech, pharma and seafood importers. Section 232 pharma readiness, HTS for biotech raw materials, Conley Terminal.
MedTech and medical device tariff advisory for Twin Cities. Medtronic, Boston Scientific, 3M suppliers. Section 232 probe readiness.
U.S. tariff advisory for Scottish whisky, salmon, oil services and medtech exporters. U.S. reciprocal, Section 232 pharma.
U.S. tariff advisory for Irish pharma, MedTech and whiskey exporters. Section 232 pharma, 232 MedTech probe, reciprocal tariff.
Robotic surgery equipment U.S. import tariff. da Vinci, MAKO, Mazor systems. HTS 9018, FDA medical device, Section 232 MedTech.
Diagnostic imaging equipment U.S. import tariff. MRI, CT, ultrasound, X-ray. HTS 9018, 9022, FDA medical device, Section 232 MedTech.
Medical device contract manufacturing imports. CMO arrangements, FDA, USMCA, transfer pricing, Section 232 MedTech.
Real-world case study showing the approach, timeline, and savings achieved by an SMB importer working with Peacock Tariff Consulting.
Duty drawback services for SMB importers. Manufacturing, unused merchandise, rejected merchandise drawback. Up to 99% recovery on exported goods.